RCS - Yourgene Health PLC - Capital Markets Day

Yourgene HealthAnnouncement

06/04/2022 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220406:nRSF3738Ha&default-theme=true

RNS Number : 3738H  Yourgene Health PLC  06 April 2022

 

Yourgene Health plc

("Yourgene" or the "Company")

 

Capital Markets Day

 

Manchester, UK - 6 April 2022: Yourgene (AIM: YGEN), a leading international
molecular diagnostics group, announces it will be holding a Capital Markets
Day for investors on Tuesday 26 April 2022.

 

The event will provide investors with a compelling opportunity to hear more
from other senior members of the management team about the roadmap and growth
plans for certain products and services, both in North America and
internationally, as well as perspectives on the dynamics within the molecular
diagnostics market and the scope for growing the Company's genomic services
business.

 

An opening and closing address will be given by CEO, Lyn Rees who will provide
an overview of the Company and where it is currently positioned. The event
will also feature presentations by:

 

·    Dr Rachel Shelmerdine, Product Management

·    Scott Sargent, Vice President, Sales Americas

·    Bhavika Patel, Technical Director, Yourgene Genomic Services

·    Jonathan Seaton, Non-Executive Director, Yourgene Health plc

 

The event will be repeated in the City of London at 4pm for non-institutional
investors and will be followed by light refreshments and an opportunity to
talk to the senior management further.

 

To register your interest please contact Walbrook PR on 020 7933 8780 or
email yourgene@walbrookpr.com (mailto:yourgene@walbrookpr.com) .

 

 

 Yourgene Health plc                              Tel: +44 (0)161 669 8122

 Lyn Rees, Chief Executive Officer                investors@yourgene-health.com (mailto:investors@yourgene-health.com)
 Barry Hextall, Chief Financial Officer
 Joanne Cross, Director of Marketing

 Singer Capital Markets (Joint Corporate Broker)  Tel: +44 (0)20 7496 3000
 Aubrey Powell / Tom Salvesen / George Tzimas

 Stifel Nicolaus Europe Limited (Joint Corporate Broker)                                 Tel: +44 (0)20 7710 7600
 Nicholas Moore / Matthew Blawat / Ben Maddison

 Walbrook PR Ltd (Media and Investor Relations)   Tel: +44 (0)20 7933 8780 or yourgene@walbrookpr.com
 Paul McManus / Lianne Applegarth /               Mob: 07980 541 893 / Mob: 07584 391 303

 Alice Woodings                                   Mob: 07407 804 654

 

 

About Yourgene Health

 

Yourgene Health is an international molecular diagnostics group which develops
and commercialises genetic products and services. The group works in
partnership with global leaders in DNA technology to advance diagnostic
science.

 

Yourgene primarily develops, manufactures, and commercialises simple and
accurate molecular diagnostic solutions, for reproductive health, precision
medicine and now infectious diseases. The Group's flagship products include
non-invasive prenatal tests (NIPT) for Down Syndrome and other genetic
disorders, Cystic Fibrosis screening tests, invasive rapid aneuploidy tests,
and a recent extension into the oncology space with DPYD genotyping.

 

The launch of Yourgene Genomic Services has enabled Yourgene to offer a global
laboratory service network equipped to be a full life-cycle partner for
clinical, research and pharmaceutical organisations to support partners at the
preclinical, clinical, and post-market stages to develop, manufacture, obtain
regulatory approval and commercialise new products and services. In addition,
Yourgene Genomic Services offers an NIPT and high throughput COVID testing
service.

 

In August 2020, Yourgene acquired Coastal Genomics, Inc., a sample preparation
technology company based in Vancouver, Canada, enabling the Company to extend
its offering and IP portfolio in the DNA sample preparation sector. The
acquisition increased Yourgene's geographical penetration into the US and
Canada, supplementing existing coverage in the UK, Europe, MEA and Asia.

 

Yourgene Health is headquartered in Manchester, UK with offices in Taipei,
Singapore, the US and Canada, and is listed on the London Stock Exchange's AIM
market under the ticker "YGEN". For more information visit
www.yourgene-health.com (http://www.yourgene-health.com/) and follow us on
twitter @Yourgene_Health.

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRAUPUUWCUPPGAA